Correlation Between Pfizer and QORVO
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and QORVO INC 4375, you can compare the effects of market volatilities on Pfizer and QORVO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of QORVO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and QORVO.
Diversification Opportunities for Pfizer and QORVO
Modest diversification
The 3 months correlation between Pfizer and QORVO is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and QORVO INC 4375 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on QORVO INC 4375 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with QORVO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of QORVO INC 4375 has no effect on the direction of Pfizer i.e., Pfizer and QORVO go up and down completely randomly.
Pair Corralation between Pfizer and QORVO
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the QORVO. In addition to that, Pfizer is 2.36 times more volatile than QORVO INC 4375. It trades about -0.13 of its total potential returns per unit of risk. QORVO INC 4375 is currently generating about -0.06 per unit of volatility. If you would invest 9,686 in QORVO INC 4375 on September 12, 2024 and sell it today you would lose (232.00) from holding QORVO INC 4375 or give up 2.4% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.31% |
Values | Daily Returns |
Pfizer Inc vs. QORVO INC 4375
Performance |
Timeline |
Pfizer Inc |
QORVO INC 4375 |
Pfizer and QORVO Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and QORVO
The main advantage of trading using opposite Pfizer and QORVO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, QORVO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in QORVO will offset losses from the drop in QORVO's long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
QORVO vs. Lifevantage | QORVO vs. Dine Brands Global | QORVO vs. RCI Hospitality Holdings | QORVO vs. Cannae Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |